About: Vepalimomab

An Entity of Type: monoclonal antibody, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Vepalimomab is an experimental mouse monoclonal antibody intended for the treatment of inflammations. It blocks vascular adhesion protein 1. Development of the drug was discontinued in 2002.

Property Value
dbo:abstract
  • Vepalimomab is an experimental mouse monoclonal antibody intended for the treatment of inflammations. It blocks vascular adhesion protein 1. Development of the drug was discontinued in 2002. (en)
dbo:casNumber
  • 195158-85-1
dbo:fdaUniiCode
  • 0M19J59UH4
dbo:wikiPageID
  • 9133272 (xsd:integer)
dbo:wikiPageLength
  • 1974 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 997516179 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • none (en)
dbp:casNumber
  • 195158 (xsd:integer)
dbp:chemspiderid
  • none (en)
dbp:mabType
  • mab (en)
dbp:source
  • o (en)
dbp:target
dbp:type
  • mab (en)
dbp:unii
  • 0 (xsd:integer)
dbp:verifiedfields
  • changed (en)
dbp:verifiedrevid
  • 470629578 (xsd:integer)
dbp:wikiPageUsesTemplate
dct:subject
gold:hypernym
rdf:type
rdfs:comment
  • Vepalimomab is an experimental mouse monoclonal antibody intended for the treatment of inflammations. It blocks vascular adhesion protein 1. Development of the drug was discontinued in 2002. (en)
rdfs:label
  • Vepalimomab (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License